Our press releases.
Vision Zero Cancer is a Swedish innovation milieu that engages actors across society in strategic actions to work jointly in the mission of beating cancer. The founders are the Confederation of Regional Cancer Centres at the Swedish Association of Local Authorities and Regions, Stockholm School of Economics, AstraZeneca and Elekta. It is managed as a partnership, led by an office at House of Innovation, Stockholm School of Economics.
Questions? Contact us at [email protected]
Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation milieu that facilitates the introduction of more precise prevention and treatment in cancer care.
To transform cancer from a deadly to a curable or chronic disease it is crucial to improve the precision in cancer treatment and follow-up of individual patients’ cancer disease. The Partnership for Precision Medicine in Cancer and Vision Zero Cancer are joining forces to accelerate research into precision medicine, with the aim to benefit every cancer patient.